A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Meeting the Decision-Making Preferences of Patients With Breast Cancer in Oncology Consultations: Impact on Decision-Related Outcomes

(2012) Richard Brown et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design

(2012) Marta Burrel et al.   JOURNAL OF HEPATOLOGY

Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

(2011) Timothy M. Pawlik et al.   JOURNAL OF CLINICAL ONCOLOGY

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization

(2011) Roopinder Gillmore et al.   JOURNAL OF HEPATOLOGY

Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?

(2011) Uzma Asghar et al.   JOURNAL OF HEPATOLOGY

Chemoembolization for intermediate HCC: Is there proof of survival benefit?

(2011) Alejandro Forner et al.   JOURNAL OF HEPATOLOGY

The Use of Transarterial Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma: A Response to the Cochrane Collaboration Review of 2011

(2011) Charles E. Ray et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells

(2010) Eunyoung Tak et al.   JOURNAL OF HEPATOLOGY

Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study

(2010) J.-F. Dufour et al.   ONCOLOGIST

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma

(2009) Katerina Malagari et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

(2009) Johannes Lammer et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)

(2008) M. Doffoël et al.   EUROPEAN JOURNAL OF CANCER